Literature DB >> 9389973

Hepatic histology of patients with HIV infection and chronic hepatitis C treated with interferon.

R Boldorini1, P Viganò, G Monga, M Nebuloni, A Cargnel, G Gubertini, G Migliaretti, G Costanzi.   

Abstract

AIMS: To evaluate the histological changes seen in liver biopsies after interferon (IFN) treatment in patients with chronic hepatitis C and human immunodeficiency virus (HIV) infection.
METHODS: Twenty four intravenous drug users with chronic hepatitis C were investigated histologically before beginning a 12 month course of IFN treatment and 18 months later. Twelve were HIV positive, without opportunistic or other viral infections (group A), and 12 were HIV negative (group B).
RESULTS: According to alanine amino-transferase concentrations, four sustained responders and eight non-responders were found in group A; six sustained responders, five relapsers, and one non-responder were found in group B. HCV RNA became negative in one sustained responder of group A and in the six sustained responders of group B. When histological findings of biopsies performed before therapy and 18 months later were compared, no significant changes in the mean value of Knodell's index and subindices were found in group A, whereas in group B Knodell's index, piecemeal necrosis, and focal hepatocellular necrosis decreased significantly.
CONCLUSIONS: In chronic hepatitis C, coinfection with HIV showed a tendency towards a lower response to IFN, although this did not reach statistical significance; however, none of the HIV positive patients developed cirrhosis during the follow up and this should be considered in clinical management of such patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9389973      PMCID: PMC500169          DOI: 10.1136/jcp.50.9.735

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  28 in total

1.  Both macrophages and endothelial cells of the human hepatic sinusoid express the CD4 molecule, a receptor for the human immunodeficiency virus.

Authors:  J Y Scoazec; G Feldmann
Journal:  Hepatology       Date:  1990-09       Impact factor: 17.425

2.  Histological outcome in interferon alpha-2b treated patients with chronic posttransfusion non-A, non-B hepatitis.

Authors:  R Schvarcz; H Glaumann; O Weiland; G Norkrans; R Wejstål; A Frydén
Journal:  Liver       Date:  1991-02

3.  Immunohistochemical evidence for human immunodeficiency virus-1 infection of liver Kupffer cells.

Authors:  C Housset; O Boucher; P M Girard; J Leibowitch; A G Saimot; C Bréchot; C Marche
Journal:  Hum Pathol       Date:  1990-04       Impact factor: 3.466

4.  Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

Authors:  A M Di Bisceglie; P Martin; C Kassianides; M Lisker-Melman; L Murray; J Waggoner; Z Goodman; S M Banks; J H Hoofnagle
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

5.  Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection.

Authors:  P Martin; A M Di Bisceglie; C Kassianides; M Lisker-Melman; J H Hoofnagle
Journal:  Gastroenterology       Date:  1989-12       Impact factor: 22.682

6.  Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha. Comparison with histological changes in chronic hepatitis B.

Authors:  M Omata; Y Ito; O Yokosuka; F Imazeki; K Uchiumi; S Takano; K Hosoda; M Ohto
Journal:  Dig Dis Sci       Date:  1989-03       Impact factor: 3.199

7.  Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.

Authors:  K Hino; S Sainokami; K Shimoda; S Iino; Y Wang; H Okamoto; Y Miyakawa; M Mayumi
Journal:  J Med Virol       Date:  1994-03       Impact factor: 2.327

8.  Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy.

Authors:  A L Barton; B F Banner; E E Cable; H L Bonkovsky
Journal:  Am J Clin Pathol       Date:  1995-04       Impact factor: 2.493

9.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.

Authors:  R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

10.  Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C.

Authors:  P Jouët; F Roudot-Thoraval; D Dhumeaux; J M Métreau
Journal:  Gastroenterology       Date:  1994-03       Impact factor: 22.682

View more
  1 in total

1.  HIV-HCV Coinfection.

Authors:  Amrita Sethi; Richard K Sterling
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.